Stable Clinical Course of Chronic Obstructive Pulmonary Disease Patients in the Era of Double Bronchodilator Therapy: A Single Referral Center Experience

Despite clinical benefits of long-acting muscarinic antagonist (LAMA)/long-acting beta2-agonist (LABA) double bronchodilator therapy, there has been limited evidence for treatment change from LAMA/LABA to inhaled corticosteroid (ICS)-containing therapy. This study aimed to assess the rate of ICS-con...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Med
Autors principals: Shin, Sun Hye, Kang, Noeul, Cho, Juhee, Choi, Yeonseok, Cho, Hyun Kyu, Choi, Hye Sook, Kim, Hojoong, Lim, Jun Hyeok, Park, Hye Yun
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7465249/
https://ncbi.nlm.nih.gov/pubmed/32781649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9082547
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars